the SmallCapReview mailing list.
Aurinia Pharmaceuticals: A
late-stage biopharmaceutical company providing novel products specifically
engineered to treat a limited, targeted patient population suffering from
serious disease states for which there is a high unmet medical need.
Myriad Genetics: A
personalized medicine company, that focuses on the
development and marketing of predictive, personalized, and
prognostic medicine tests worldwide.
MYGN has a collaboration with AstraZeneca for the
development of an indication for BRACAnalysis CDx.
Hispanica International: Is
engaged in the distribution of proprietary, licensed and third party
Hispanic and Ethnic food and beverages throughout the United States.
added over 1,400 retailers to now surpass 2,000 retail locations and will
expand to over 5,000 retail locations. More.
Where Small Cap Stocks Thrive Since
Cap Stocks On The Move: AMTX Up 148%, TGLT Up 26%, ZSAN Up 16%, AUPH Up
Stocks Could Be The Big Winners This Year As Trump Pivots
The small-cap focused
Russell 2000 is up nearly 5 percent since President Donald Trump announced
he wanted to implement tariffs. The large-cap S&P 500 index is
up just 1.3 percent in that time.
Cap Stocks March Ahead...
Caps Stocks Are Doing Something They Haven't Done In 3 Years...
Small Cap Stocks Are Outperforming...
Cap Stocks Find Favor As Trade War Fears Spike...
Meaningful Move In Small Cap Stocks...
It Time To Rotate Into Small Caps?
Small Caps To Beat The Market...
Aurinia Pharmaceuticals (AUPH) Be A Millionaire-Maker Stock?
(AUPH) Named Company Of The Year By Life Sciences BC...
To Google This Has More Relevance For Those Searching "Small Cap
Stocks" Than SmallCapReview... The
New England Farmer from 1860.
Twitter, Social Media Boost Small Cap Stocks...
(AUPH) Launches Lupus-Nephritis Awareness Program...
Going Wild But Small Cap Stocks Are Holding Up...
Cap Value Stocks Are On Sale...
Caps To Watch...
Cap IR By The Numbers... Average
Small Cap IR budget: $224,000, with $78,000 spent on external services.
has the deepest diagnostic pipeline across the disease spectrum."
on MYGN here...
has the potential to become a best in class medication and the first
approved treatment for LN in the U.S. and Europe."
on AUPH here...
Bring Latin America And The World To You."
on HISP here...
Subscribers to our Free
newsletter will receive stock reports and news alerts for small-cap stocks
via email. You can sign-up
"A Primer In
is a leading destination for small-cap picks and news. The Purpose of
is to profile and bring awareness to companies with a market cap of
less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap
stocks to watch via various newswires. We will strive to bring you the
undiscovered, the undervalued, and the oversold.
does not give "buy" recommendations, price targets nor
suggest entry and exit points.
"A Look at Small Cap Stocks that may no longer be Small Caps"